Association between phenotypic features of blasts and the blast percentage in bone marrow of patients with myelodysplastic syndromes

被引:11
作者
Ogata, K
Satoh, C
Hyodo, H
Tamura, H
Dan, K
Yoshida, Y
机构
[1] Nippon Med Coll, Dept Internal Med 3, Div Hematol, Bunkyo Ku, Tokyo 1138603, Japan
[2] Takeda Gen Hosp, Div Hematol, Fushimi Ku, Kyoto 6011495, Japan
基金
日本学术振兴会;
关键词
myelodysplastic syndromes; classification; blasts; immunophenotypes;
D O I
10.1016/j.leukres.2004.03.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although the blast percentage in the bone marrow (BM) is a key parameter for the classification of myelodysplastic syndromes (MDS), the current blast percentages used to define MDS subtypes have not been shown to have strong biological relevance. We determined the blast phenotypes and examined their relationship with the BM blast percentage in 90 MDS cases. When the BM blast percentage increased, cases whose blasts expressed CD7, CD56 and CD117 increased whereas cases whose blasts expressed CD10, CD11b and CD15 decreased. The BM blast percentages where the blast immunophenotype changed were 5, 10, 20 and 25%. Blast immunophenotypes have the potential to provide a biological basis for and refine the present MDS classifications. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1171 / 1175
页数:5
相关论文
共 15 条
[1]  
[Anonymous], 2000, IMMUNOPHENOTYPING
[2]  
BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x
[3]   IMMUNOPHENOTYPING OF ACUTE-LEUKEMIA BY FLOW CYTOMETRIC ANALYSIS - USE OF CD45 AND RIGHT-ANGLE LIGHT SCATTER TO GATE ON LEUKEMIC BLASTS IN 3-COLOR ANALYSIS [J].
BOROWITZ, MJ ;
GUENTHER, KL ;
SHULTS, KE ;
STELZER, GT .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 100 (05) :534-540
[4]  
CASON JD, 1989, BLOOD, V74, P1758
[5]  
CHABANNON C, 1992, J IMMUNOL, V149, P2110
[6]   POLYMORPHONUCLEAR NEUTROPHILS EXPRESS THE COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA ANTIGEN [J].
COSSMAN, J ;
NECKERS, LM ;
LEONARD, WJ ;
GREENE, WC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (03) :1064-1069
[7]  
FOUCAR K, 1985, CANCER, V56, P553, DOI 10.1002/1097-0142(19850801)56:3<553::AID-CNCR2820560323>3.0.CO
[8]  
2-Q
[9]   International scoring system for evaluating prognosis in myelodysplastic syndromes [J].
Greenberg, P ;
Cox, C ;
LeBeau, MM ;
Fenaux, P ;
Morel, P ;
Sanz, G ;
Sanz, M ;
Vallespi, T ;
Hamblin, T ;
Oscier, D ;
Ohyashiki, K ;
Toyama, K ;
Aul, C ;
Mufti, G ;
Bennett, J .
BLOOD, 1997, 89 (06) :2079-2088
[10]   UTILITY OF THE FAB CLASSIFICATION FOR MYELODYSPLASTIC SYNDROMES - INVESTIGATION OF PROGNOSTIC FACTORS IN 237 CASES [J].
KERKHOFS, H ;
HERMANS, J ;
HAAK, HL ;
LEEKSMA, CHW .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (01) :73-81